{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:44:18Z","timestamp":1762821858183,"version":"build-2065373602"},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.retram.2023.103423","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T13:00:04Z","timestamp":1697634004000},"page":"103423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2813-5372","authenticated-orcid":false,"given":"Wendy","family":"Cuccuini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Agnes","family":"Collonge-Rame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Auger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Douet-Guilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Coster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Lafage-Pochitaloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.retram.2023.103423_bib0001","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med"},{"issue":"S1","key":"10.1016\/j.retram.2023.103423_bib0002","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5045\/br.2022.2022056","article-title":"Genetics and genomics of bone marrow failure syndrome","volume":"57","author":"Kim","year":"2022","journal-title":"Blood Res"},{"issue":"4","key":"10.1016\/j.retram.2023.103423_bib0003","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.hoc.2018.04.008","article-title":"Introduction to acquired and inherited bone marrow failure","volume":"32","author":"Sieff","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.retram.2023.103423_bib0004","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.hoc.2018.03.001","article-title":"The pathophysiology of acquired aplastic anemia: current concepts revisited","volume":"32","author":"Schoettler","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.2019000940","article-title":"Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria","volume":"136","author":"Sun","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2023.103423_bib0006","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1182\/blood.2020006481","article-title":"Inherited bone marrow failure in the pediatric patient","volume":"140","author":"Dokal","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2023.103423_bib0007","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2020.101197","article-title":"Germline predisposition in myeloid neoplasms: unique genetic and clinical features of GATA2 deficiency and SAMD9\/SAMD9L syndromes","volume":"33","author":"Sahoo","year":"2020","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.retram.2023.103423_bib0009","article-title":"Aplasies m\u00e9dullaires acquises et constitutionnelles PNDS 2023","author":"Leblanc","year":"2023","journal-title":"HAS"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10428190310001602363","article-title":"Evolution of clonal cytogenetic abnormalities in aplastic anemia","volume":"45","author":"Maciejewski","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2141.2003.04562.x","article-title":"Cytogenetic abnormalities in paroxysmal nocturnal haemoglobinuria usually occur in haematopoietic cells that are glycosylphosphatidylinositol-anchored protein (GPI-AP) positive","volume":"123","author":"Sloand","year":"2003","journal-title":"Br J Haematol"},{"issue":"17","key":"10.1016\/j.retram.2023.103423_bib0012","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1182\/blood-2014-05-574889","article-title":"Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome","volume":"124","author":"Kulasekararaj","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.retram.2023.103423_bib0013","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2014-10-607572","article-title":"Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia","volume":"125","author":"Dumitriu","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2023.103423_bib0014","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/ejh.13153","article-title":"Aplastic anemia: etiology, molecular pathogenesis, and emerging concepts","volume":"101","author":"Shallis","year":"2018","journal-title":"Eur J Haematol"},{"issue":"9","key":"10.1016\/j.retram.2023.103423_bib0015","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V99.9.3129","article-title":"Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia","volume":"99","author":"Maciejewski","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0016","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2141.2002.03518.x","article-title":"Aplastic anaemia with 13q-: a benign subset of bone marrow failure responsive to immunosuppressive therapy","volume":"117","author":"Ishiyama","year":"2002","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0017","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.retram.2023.103423_bib0018","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/bjh.14510","article-title":"Recent advances in understanding clonal haematopoiesis in aplastic anaemia","volume":"177","author":"Stanley","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103423_bib0019","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2023020108","article-title":"IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria","author":"Gurnari","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.2006.06105.x","article-title":"Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults","volume":"134","author":"Gupta","year":"2006","journal-title":"Br J Haematol"},{"issue":"25","key":"10.1016\/j.retram.2023.103423_bib0021","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1182\/blood-2011-07-365189","article-title":"Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia","volume":"118","author":"Katagiri","year":"2011","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.retram.2023.103423_bib0022","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1182\/blood-2010-11-314393","article-title":"SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes","volume":"117","author":"Afable","year":"2011","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.retram.2023.103423_bib0023","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2016-11-752378","article-title":"Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia","volume":"129","author":"Zaimoku","year":"2017","journal-title":"Blood."},{"issue":"16","key":"10.1016\/j.retram.2023.103423_bib0024","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/bloodadvances.2021004201","article-title":"The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis","volume":"5","author":"Shah","year":"2021","journal-title":"Blood Adv"},{"issue":"17","key":"10.1016\/j.retram.2023.103423_bib0025","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood-2017-02-767731","article-title":"Origins of myelodysplastic syndromes after aplastic anemia","volume":"130","author":"Negoro","year":"2017","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0026","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1200\/JCO.22.00710","article-title":"Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria","volume":"41","author":"Gurnari","year":"2023","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.retram.2023.103423_bib0027","article-title":"Insights into the emergence of paroxysmal nocturnal hemoglobinuria","volume":"12","author":"Colden","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2023.103423_bib0028","first-page":"143","volume":"2021","author":"Babushok","year":"2021"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0029","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.seminhematol.2022.08.004","article-title":"Somatic mutations and clonal expansions in paroxysmal nocturnal hemoglobinuria","volume":"59","author":"Hosokawa","year":"2022","journal-title":"Semin Hematol"},{"issue":"7","key":"10.1016\/j.retram.2023.103423_bib0030","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00277-020-04052-z","article-title":"Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry","volume":"99","author":"Schrezenmeier","year":"2020","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0031","first-page":"313","article-title":"Paroxysmal nocturnal hemoglobinuria with deletion of chromosome 13q (q12q14): a case report and review of the literature","volume":"42","author":"Kim","year":"2012","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0032","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/ejh.12484","article-title":"Increased glycosylphosphatidylinositol-anchored protein-deficient granulocytes define a benign subset of bone marrow failures in patients with trisomy 8","volume":"95","author":"Hosokawa","year":"2015","journal-title":"Eur J Haematol"},{"issue":"12","key":"10.1016\/j.retram.2023.103423_bib0033","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1172\/JCI123501","article-title":"Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation","volume":"129","author":"H\u00f6chsmann","year":"2019","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0034","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/hematology.2019000019","article-title":"Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome","volume":"2019","author":"Durrani","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.retram.2023.103423_bib0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/asheducation-2011.1.90","article-title":"Clonal evolution in aplastic anemia","volume":"2011","author":"Afable","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0036","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood-2016-01-636381","article-title":"Clonal hematopoiesis in acquired aplastic anemia","volume":"128","author":"Ogawa","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.retram.2023.103423_bib0037","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1038\/s41375-019-0457-1","article-title":"Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome","volume":"33","author":"Bono","year":"2019","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.retram.2023.103423_bib0038","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1080\/10428194.2018.1543885","article-title":"BCOR and BCORL1 mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomes","volume":"60","author":"Abuhadra","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.retram.2023.103423_bib0039","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bjh.18330","article-title":"GATA2 deficiency and MDS\/AML: experimental strategies for disease modelling and future therapeutic prospects","volume":"199","author":"Kotmayer","year":"2022","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.retram.2023.103423_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2021.101278","article-title":"GATA2 and marrow failure","volume":"34","author":"Fabozzi","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"issue":"11","key":"10.1016\/j.retram.2023.103423_bib0041","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/humu.24271","article-title":"GATA2 deficiency syndrome: a decade of discovery","volume":"42","author":"Homan","year":"2021","journal-title":"Hum Mutat"},{"issue":"10","key":"10.1016\/j.retram.2023.103423_bib0042","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","article-title":"Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes","volume":"27","author":"Sahoo","year":"2021","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.retram.2023.103423_bib0043","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2017.181909","article-title":"Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients","volume":"103","author":"Donadieu","year":"2018","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.retram.2023.103423_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26419","article-title":"A case of GATA2-related myelodysplastic syndrome with unbalanced translocation der(1;7)(q10;p10)","volume":"64","author":"Kurata","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.retram.2023.103423_bib0045","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.hoc.2018.04.007","article-title":"Monosomy 7 in pediatric myelodysplastic syndromes","volume":"32","author":"Wlodarski","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"10.1016\/j.retram.2023.103423_bib0046","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1182\/blood.2020005538","article-title":"Somatic genetic rescue in hematopoietic cells in GATA2 deficiency","volume":"136","author":"Catto","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0047","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3324\/haematol.2017.180778","article-title":"Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7","volume":"103","author":"Pastor","year":"2018","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.retram.2023.103423_bib0048","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/s41375-021-01212-6","article-title":"Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells","volume":"35","author":"Thomas","year":"2021","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.retram.2023.103423_bib0049","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.3569","article-title":"SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.retram.2023.103423_bib0050","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ajhg.2016.04.009","article-title":"Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L","volume":"98","author":"Chen","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"14","key":"10.1016\/j.retram.2023.103423_bib0051","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121086","article-title":"Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes","volume":"3","author":"Wong","year":"2018","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.retram.2023.103423_bib0052","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/leu.2017.142","article-title":"Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome","volume":"31","author":"Schwartz","year":"2017","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.retram.2023.103423_bib0053","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2016-10-743302","article-title":"Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms","volume":"129","author":"Tesi","year":"2017","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0054","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrc.2017.116","article-title":"Fanconi anaemia and cancer: an intricate relationship","volume":"18","author":"Nalepa","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.retram.2023.103423_bib0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrm.2016.48","article-title":"The Fanconi anaemia pathway: new players and new functions","volume":"17","author":"Ceccaldi","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0056","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2004-05-1852","article-title":"Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA\/BRCA pathway","volume":"105","author":"Soulier","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0057","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/hematology.2021000271","article-title":"Mechanisms of somatic transformation in inherited bone marrow failure syndromes","volume":"2021","author":"Choijilsuren","year":"2021","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.retram.2023.103423_bib0058","article-title":"Diagnosis of Fanconi anemia by diepoxybutane analysis","volume":"85","author":"Auerbach","year":"2015","journal-title":"Curr Protoc Hum Genet"},{"issue":"4","key":"10.1016\/j.retram.2023.103423_bib0059","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3324\/haematol.13592","article-title":"Diagnosis of Fanconi anemia in patients with bone marrow failure","volume":"94","author":"Pinto","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103423_bib0060","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/asheducation-2011.1.492","article-title":"Fanconi anemia","volume":"2011","author":"Soulier","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"15","key":"10.1016\/j.retram.2023.103423_bib0061","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1182\/blood-2010-09-308726","article-title":"Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions","volume":"117","author":"Quentin","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0062","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1309\/AJCP7W9VMJENZOVG","article-title":"Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics","volume":"133","author":"Cioc","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"24","key":"10.1016\/j.retram.2023.103423_bib0063","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1182\/blood-2016-01-583625","article-title":"How I treat MDS and AML in Fanconi anemia","volume":"127","author":"Peffault de Latour","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.retram.2023.103423_bib0064","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.stem.2023.01.006","article-title":"Clonal hematopoiesis driven by chromosome 1q\/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia","volume":"30","author":"Sebert","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"22","key":"10.1016\/j.retram.2023.103423_bib0065","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1182\/blood-2011-03-343897","article-title":"Fanconi anemia (FA)-associated 3q gains in leukemic transformation consistently target EVI1, but do not affect low TERC expression in FA","volume":"117","author":"Meyer","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0066","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/hematology.2022000394","article-title":"Dyskeratosis congenita and telomere biology disorders","author":"Savage","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"12","key":"10.1016\/j.retram.2023.103423_bib0067","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","article-title":"An update on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"12","author":"Niewisch","year":"2019","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0068","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41525-021-00198-5","article-title":"Telomere biology disorders","volume":"6","author":"Kam","year":"2021","journal-title":"NPJ Genomic Med"},{"issue":"4","key":"10.1016\/j.retram.2023.103423_bib0069","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/leu.2011.272","article-title":"Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia","volume":"26","author":"Calado","year":"2012","journal-title":"Leukemia"},{"issue":"22","key":"10.1016\/j.retram.2023.103423_bib0070","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood.2019003264","article-title":"Cancer spectrum and outcomes in the Mendelian short telomere syndromes","volume":"135","author":"Schratz","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0071","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11899-022-00662-8","article-title":"Clonal hematopoiesis and myeloid neoplasms in the context of telomere biology disorders","volume":"17","author":"Ferrer","year":"2022","journal-title":"Curr Hematol Malig Rep"},{"issue":"26","key":"10.1016\/j.retram.2023.103423_bib0072","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1182\/blood-2011-08-375170","article-title":"Ribosomal protein gene deletions in Diamond-Blackfan anemia","volume":"118","author":"Farrar","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.retram.2023.103423_bib0073","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1182\/blood-2011-07-368662","article-title":"Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia","volume":"119","author":"Kuramitsu","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0074","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajhg.2018.07.020","article-title":"De Novo mutations activating germline TP53 in an inherited bone-marrow-failure syndrome","volume":"103","author":"Toki","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.retram.2023.103423_bib0075","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood.2019000947","article-title":"Diamond-Blackfan anemia","volume":"136","author":"Da Costa","year":"2020","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.retram.2023.103423_bib0076","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1182\/blood.2021011846","article-title":"HEATR3 variants impair nuclear import of uL18 (RPL5) and drive Diamond-Blackfan anemia","volume":"139","author":"O'Donohue","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.retram.2023.103423_bib0077","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/5951","article-title":"The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia","volume":"21","author":"Draptchinskaia","year":"1999","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.retram.2023.103423_bib0078","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3324\/haematol.2014.117457","article-title":"The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes","volume":"100","author":"Cada","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0079","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103423_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jbior.2017.09.002","article-title":"Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome","volume":"67","author":"Warren","year":"2018","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.retram.2023.103423_bib0081","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpeds.2019.12.041","article-title":"A prospective study of hematologic complications and long-term survival of Italian patients affected by Shwachman-Diamond syndrome","volume":"219","author":"Cesaro","year":"2020","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.retram.2023.103423_bib0082","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3324\/haematol.2011.057489","article-title":"Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome","volume":"97","author":"Donadieu","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.retram.2023.103423_bib0083","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40291-018-0368-2","article-title":"Shwachman-Diamond syndrome: molecular mechanisms and current perspectives","volume":"23","author":"Bezzerri","year":"2019","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0084","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/bloodadvances.2021005539","article-title":"Hematologic complications with age in Shwachman-Diamond syndrome","volume":"6","author":"Furutani","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0085","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13039-021-00575-w","article-title":"The frequent and clinically benign anomalies of chromosomes 7 and 20 in Shwachman-Diamond syndrome may be subject to further clonal variations","volume":"14","author":"Khan","year":"2021","journal-title":"Mol Cytogenet"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0086","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41467-021-21588-4","article-title":"Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome","volume":"12","author":"Kennedy","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0087","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1038\/s41467-021-24999-5","article-title":"Somatic genetic rescue of a germline ribosome assembly defect","volume":"12","author":"Tan","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0088","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/s41467-022-29214-7","article-title":"eIF6 rebinding dynamically couples ribosome maturation and translation","volume":"13","author":"Jaako","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.retram.2023.103423_bib0089","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2352-3026(19)30206-6","article-title":"Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study","volume":"7","author":"Myers","year":"2020","journal-title":"Lancet Haematol"},{"issue":"2","key":"10.1016\/j.retram.2023.103423_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2021.101286","article-title":"Congenital amegakaryocytic thrombocytopenia - not a single disease","volume":"34","author":"Germeshausen","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"issue":"6","key":"10.1016\/j.retram.2023.103423_bib0091","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.ajhg.2015.10.010","article-title":"Mutations in MECOM, encoding oncoprotein EVI1, cause radioulnar synostosis with amegakaryocytic thrombocytopenia","volume":"97","author":"Niihori","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.retram.2023.103423_bib0092","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2003.tb03228.x","article-title":"Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia","volume":"996","author":"Ballmaier","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.retram.2023.103423_bib0093","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2141.2005.05819.x","article-title":"Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients","volume":"131","author":"King","year":"2005","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.retram.2023.103423_bib0094","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3324\/haematol.12748","article-title":"Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498)","volume":"93","author":"Maserati","year":"2008","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.retram.2023.103423_bib0095","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pbc.20332","article-title":"Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7","volume":"45","author":"Steele","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.retram.2023.103423_bib0096","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1182\/bloodadvances.2021004345","article-title":"Approach to the diagnosis of aplastic anemia","volume":"5","author":"DeZern","year":"2021","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.retram.2023.103423_bib0097","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/ajh.26310","article-title":"Diagnostic work-up for severe aplastic anemia in children: consensus of the North American pediatric aplastic anemia consortium","volume":"96","author":"Shimano","year":"2021","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.retram.2023.103423_bib0098","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/hematology.2022000393","article-title":"Modern management of Fanconi anemia","author":"Dufour","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:41:12Z","timestamp":1762821672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318623000478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2452318623000478"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2023.103423","relation":{},"ISSN":["2452-3186"],"issn-type":[{"type":"print","value":"2452-3186"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2023.103423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103423"}}